ScholarIQanswers from OpenAlex
Associazione Nazionale Medici Cardiologi Ospedalieri
InstitutionResearch output, impact & collaborations
Associazione Nazionale Medici Cardiologi Ospedalieri is a institution indexed in ScholarIQ from OpenAlex.
What is known about Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQrecord summary
Associazione Nazionale Medici Cardiologi Ospedalieri is a research organisation in Florence, IT. OpenAlex records 1,372 works and 540,408 citations for it. 652 researchers list it as their most recent affiliation.
How many works does Associazione Nazionale Medici Cardiologi Ospedalieri have?
ScholarIQindexed works
Associazione Nazionale Medici Cardiologi Ospedalieri has 1,372 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Associazione Nazionale Medici Cardiologi Ospedalieri have?
ScholarIQcitation count
Associazione Nazionale Medici Cardiologi Ospedalieri has 540,408 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQresearcher count
Associazione Nazionale Medici Cardiologi Ospedalieri has 652 researchers in the ScholarIQ index.
What is the average h-index at Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQavg h-index
Associazione Nazionale Medici Cardiologi Ospedalieri has an average h-index of 123 in OpenAlex.
What is the ROR of Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQror
The ROR for Associazione Nazionale Medici Cardiologi Ospedalieri is on the source record.
What is the OpenAlex record for Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQopenalex
The OpenAlex for Associazione Nazionale Medici Cardiologi Ospedalieri is on the source record.
Who are the most-cited researchers behind Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQtop researchers by citations
What are the most-cited papers on Associazione Nazionale Medici Cardiologi Ospedalieri?
ScholarIQmost cited works
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters, Olivier F. Bertrand, Rafael Díaz, Aldo P. Maggioni, Fausto J. Pinto, Réda Ibrahim, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Petr Ošťádal, Wolfgang Köenig, Denis Angoulvant, Jean C. Grégoire, Marc-André Lavoie, Marie‐Pierre Dubé, David Rhainds, Mylène Provencher, Lucie Blondeau, Andreas Orfanos, Philippe L. L’Allier, Marie‐Claude Guertin, François Roubille
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer, John J.V. McMurray, Eric J. Velazquez, Jean‐Lucien Rouleau, Lars Køber, Aldo P. Maggioni, Scott D. Solomon, Karl Swedberg, Frans Van de Werf, Harvey D. White, Jeffrey D. Leimberger, Marc Henis, Susan Edwards, Steven L. Zelenkofske, Mary Ann Sellers, Robert M. Califf
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Díaz, Marco Alings, Eva Lonn, Sonia S. Anand, Petr Widimský, Masatsugu Hori, Álvaro Avezum, Leopoldo Soares Piegas, Kelley R. Branch, Jeffrey L. Probstfield, Deepak L. Bhatt, Jun Zhu, Yan Liang, Aldo P. Maggioni, Patricio López‐Jaramillo, Martin O’Donnell, Ajay K. Kakkar, Keith A.A. Fox, Alexander Parkhomenko, Georg Ertl, Stefan Störk, Mátyás Keltai, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
How much of the research on Associazione Nazionale Medici Cardiologi Ospedalieri is open access?
ScholarIQopen access share
83%OPEN ACCESS